Coronary/Structural Heart

Infraredx, a Nipro Company, Announces FDA Approval of Expanded Label Claim for the Makoto™ Intravascular Imaging System

BURLINGTON, Mass.–(BUSINESS WIRE)–Infraredx, a Nipro Company, a pioneer in intravascular imaging for mapping coronary artery disease, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the indications for use for its Makoto™ Intravascular Imaging System. The approval is based on the […]

VisCardia Announces Completion of Enrollment and Three Month Follow-Up Visits for Its VisONE® Heart Failure Pilot Study

PORTLAND, Ore.–(BUSINESS WIRE)–VisCardia Inc., a privately held medical device developer, announced today it has completed enrollment and three month follow-up visits of the company’s VisONE® implantable system pilot for medical refractory heart failure patients with reduced ejection fraction and preserved ventricular synchrony. The VisONE Heart Failure pilot is a prospective […]

Quantum Genomics Receives First Regulatory and Ethics Approvals to Initiate Phase IIb QUORUM Study of Firibastat in Heart Failure

PARIS and NEW YORK, April 17, 2019 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth: ALQGC, OTCQX: QNNTF), a biopharmaceutical company specializing in the development of a new drug class that directly targets the brain to treat resistant hypertension and heart failure, today announced the first regulatory and ethics approvals for its Phase […]

HonorHealth Research Institute launches study to research benefit to patients at high risk of bleeding after coronary stent implantation

SCOTTSDALE, Ariz., April 16, 2019 /PRNewswire/ — HonorHealth Research Institute announced that the first patients have been enrolled in the SynIVUS-DAPT Study, a clinical study designed to test outcomes of decreasing the amount of time patients, with a high risk of bleeding, take antiplatelet medications after receiving a drug-eluting coronary stent. “People who […]

CDC Foundation, Amgen Announce Program to Increase Awareness and Knowledge of Cardiovascular Diseases Globally

ATLANTA, April 17, 2019 /PRNewswire/ — According to the World Health Organization (WHO), cardiovascular disease (CVD) is the leading cause of death worldwide, responsible for nearly 18 million deaths in 2016 alone. More than three-quarters of these deaths occur in low- and middle-income countries. To increase understanding of this globally important issue, […]

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

VANCOUVER, April 17, 2019 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that the International Journal of Cardiology (the “IJC”) has published […]

CHF Solutions Announces Launch of Ultrafiltration Program at Heart Hospital at Saint Francis

EDEN PRAIRIE, Minn., April 16, 2019 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS) today announced that Heart Hospital at Saint Francis has launched an ultrafiltration program using the Aquadex FlexFlow® system to assist in the management of fluid overload in patients following cardiac surgery and in patients suffering from heart […]

Ortho’s VITROS® High Sensitivity Troponin I Assay for the Diagnosis of Heart Attack Now CE Marked, Available in EU Countries

RARITAN, N.J., April 16, 2019 /PRNewswire/ — Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced CE Mark for its next-generation VITROS® High Sensitivity Troponin I assay. This new assay is the latest addition to the company’s robust cardiology menu and is a critical tool for clinicians who are seeking improved […]

Corindus Announces First Robotic-Assisted Interventions in Japan for CorPath GRX Post-Market Study

WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that the first clinical robotic-assisted PCI procedures in Japan were completed in partnership with Takafumi Ueno, MD, PhD, Director of Interventional Cardiology, Center of Cardiovascular Disease, Kurume University Hospital. These […]

FH Foundation Expands FIND FH® to Speed Diagnosis of Individuals with Homozygous Familial Hypercholesterolemia

PASADENA, Calif., April 11, 2019 /PRNewswire/ — Today, the FH Foundation announced the launch of the FIND HoFH program to identify individuals at risk for homozygous familial hypercholesterolemia (HoFH). The goal is to accelerate the diagnosis of this life-threatening condition. HoFH is a more severe form of familial hypercholesterolemia (FH), that can lead to heart […]